20 GMP Certificate

Name: Manufacturer for High Content Fish Oil EPA/DHA 40/20 GMP Certificate
Brand: Shandong Yuwang Pharmaceutical Co., Ltd.
SKU: 922642795

Shandong, ChinaShandong Yuwang Pharmaceutical Co., Ltd.

US$49.00

190 kg

Product profile

Customization

Available

Type

Fish Oil

Resource

Animal Fat

Processing Method

Boiling

Packaging

Drum

Warranty

24 Months

Transport Package

Drum

Specification

460/380

Trademark

Yuwang

Origin

China

HS Code

150420

Production Capacity

500000

Company profile

Shandong Yuwang Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2000-09-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤2.21h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryShandong Yuwang Pharmaceutical Co., Ltd. is identified as a Chinese manufacturer established in 1994, with operations in Shandong and products including fish oil, softgels, hard capsules, and tablets. The supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 certifications, more than 10 production lines, annual capsule capacity of 10 billion units, and export markets across South America, Europe, and North America. Its stated quality objectives emphasize zero defects and zero complaints. Evidence also indicates R&D personnel, quality-control staff, export experience since 2000, and a named buyer. However, the provided information does not sufficiently establish after-sales processes, financial credibility, or product customization capability.

Supplier typeThe supplier is explicitly classified as a manufacturer, and its business scope covers the manufacture and sale of functional food and related forms such as capsules, tablets, and powder. Its stated product keywords include fish oil, fish oil softgels, hard capsules, and tablets.

CertificationsThe supplier reports holding ISO9001:2015, ISO14001:2015, and ISO45001:2016 certificates, along with other unspecified certifications. These are explicit management-system certification claims, although the specific scope and validity of the unspecified certificates are not provided.

R&D capabilityThe supplier explicitly states a commitment to continuous improvement and innovation and reports nine R&D engineers. This supports the existence of an innovation-oriented policy and dedicated R&D personnel, but no specific newly developed products, patents, or measurable innovation outcomes are provided.

Production capacityThe supplier reports more than 10 production lines, annual production capacity of 10 billion capsules, a 21,000 m² manufacturing plant, and one-month fulfillment times in both peak and off-peak seasons. These stated scale and capacity indicators provide explicit evidence of substantial production capability.

Client casesThe supplier reports exports to South America, Europe, and North America, and transaction records associate it with CÔNG TY CỔ PHẦN DƯỢC PHẨM AMPHARCO U S A. These records demonstrate international market activity and at least one associated buyer, but they do not provide customer feedback, project details, order outcomes, or independently verified case performance.